Radionuclide imaging in risk assessment after acute coronary syndromes

Heart

Volumn 90, Issue SUPPL. 5, 2004, Pages

  Udelson, J E ^a   Flint, E J ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Wordsley Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ADENOSINE; ANNEXIN; BIOLOGICAL MARKER; CREATINE KINASE MB; DIPYRIDAMOLE; ENZYME; FATTY ACID; IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; TETROFOSMIN TC 99M; THALLIUM 201; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN;

ACUTE DISEASE; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EMERGENCY WARD; ENZYMATIC ASSAY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FATTY ACID METABOLISM; HEART CATHETERIZATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; Q WAVE; RADIOISOTOPE VENTRICULOGRAPHY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SYMPATHETIC INNERVATION; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED KINGDOM; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; CHEST PAIN; EMERGENCY SERVICE, HOSPITAL; FORECASTING; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS; RADIONUCLIDE ANGIOGRAPHY; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 3442895112     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.041194     Document Type: Article

References (61)

1. Department of Health (2000). National service framework for coronary heart disease http://ww.doh.gov.uk/nsf/coronary.htm.
2. Underwood SR, Godman B, Salyani, et al. Economics of myocardial perfusion imaging in Europe - EMPIRE Study. Eur Heart J 1999;20:157-66.
3. British Cardiac Society Guidelines, and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit (2001). Guidelines for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. Heart 2001;85:133-42.
4. Farkouh ME, Smars P, Reeder GS, et al. A clinical trial of a chest pain observation unit for patients with unstable angina. N Eng J Med 1998;339:1882-8.
5. Goodacre SW. Should we establish chest pain observation units in the UK? A systematic review and critical appraisal or the literature. J Acid Emerg Med 2000;17(S):1-6.
6. Stratmann HG, Younis LT, Wittry MD, et al. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995;76:235-40.
7. Stratman HG, Tamesis BR, Younis LT, et al. Prognostic value of predischarge dipyridamole technetium sestamibi myocardial tomography in medically treated patient with unstable angina. Am Heart J 1995;130:734-40.
8. Wackers FJT, Lie KI, Liem KL, et al. Potential value of thaliium-201 scintigraphy as a means of selecting patients for the coronary care unit Br. Heart J 1979;41:111-7.
9. Beller GA, Radiopharmaceuticals in nuclear cardiology In: Beller GA, eds. Clinical nuclear cardiology. Philadelphia: Saunders, 1995:37-81.
10. Bilodeau L, Theroux P, Gregoire J, et al. Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical electrocardiographic and angiographic findings. J Am Coll Cardiol 1991;18:1684-91.
11. Christian TF, Clements IP, Gibbons RJ, et al. Non-invasive identification of myocardium at risk in patients with acute myocardial infarction and non diagnostic electrocardiograms with technetium-99m sestamibi. Circulation 1991;83:1615-20.
12. Varetto T, Cantalupi D, Altieri A, et al. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischaemic events in patients with non diagnostic electrocardiograpny. J Am Coll Cardiol 1993;22:1804-8.
13. Hilton TC, Thompson RC, Williams H, et al. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994;23:1016-22.
14. Tatum JL, Jesse RI, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997;29:116-25.
15. Heller GV, Stowers SA, Hendel RC, et al. Clincal value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and non diagnostic electrocardiogram. J Am Coll Cardiol 1998;31:1011-7.
16. Kontos MC, Jesse RL, Anderson P, et al. Comparison of myocardial perfusion imaging and cardiac tropanin I in patients admitted to the emergency department with chest pain. Circulation 1999;99:2073-8.
17. Stowers SA, Eisenstein EL, Wackers FJ, et al. An economic analysis of an aggressive diagnostic strategy with single photonemission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but non diagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med 2000;35:17-25.
18. nd American Heart Association. Atlanta: American Heart Association, 1999.
19. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines of the management of patients with unstable angina and non ST segment elevation myocardial infarction: executive summary and recommendations: a repart of the ACC/AHA taskforce on practice guidelines. Circulation 2000;102:1193-209.
20. Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association. Circulation 1999;100:1016-30.
21. Joint Royal College of Physicians/British Cardiac Society. Fifth report on the provision of services for patients with heart disease. Heart 2002;88(suppl III):iii1-iii59.
22. Ziffer JA, Nateman DR, Janowitz WR, et al. Improved patient outcomes and cost effectiveness of utilizing nuclear cardiology protocols in an emergency department chest pain centre. J Nucl Med. 1998;39: 13 [astract]).
23. Braunwald EB, et al. Unstable Angina Clinical Practice Guideline Number 10. Agency for Health Care Policy and Research publication No. 94-0602, 1994.
24. Brown KA. Management of unstable angina: the role on noninvasive risk stratification. J Nucl Cardiol 1997;4:S164-8.
25. Klocke FJ, Baird MG, Lorell BH, et al. Guidelines for clinical use of cardiac radionuclide imaging. J Am Coll Cardiol 2003;42:1318-33.
26. The TIMI-III-B investigators. Effects of tissue plaminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI-III B Trial Thrombolysis and Myocardial Ischaemia. Circulation 1994;89:1545-56.
27. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared to a conservative management strategy: Veteran affairs non-Q-wave infarction strategies in hospital (VANQUISH) trial investigators. N Engl J Med 1998;338:1785-92.
28. FRISC II Investigators. Invasive compared with non invasive treatment in unstable coronary artery disease: FRISC-II prospective randomized multicentre study. Lancet 1999;354:708-15.
29. Cannon CP, Weintraub WS, Demopaulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofibon. N Engl J Med 2001;344:1879-87.
30. Barnett PG, Cheo S, Boden WE, et al. Cost-effectiveness of a conservative, ischaemia guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation 2002;105:680-4.
31. Goyal A, Samaha FF, Boden WE, et al. Stress test criteria used in the conservative arm of FRISC-II underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial. J Am Coll Cardiol 2002;39:1601-7.
32. Mark DB, Lee TH. Conservative management of acute coronary syndrome. Cheaper and better for you? Circulation 2002;105:666-8.
33. Mehta S, Yousuf S, Hunt D, et al. Invasive versus conservative management of unstable angina and non Q-wave myocardial infarction: a meta-analysis. Circulation 1999;100:1-775.
34. Dargie H. Myocardial infarction: redefined or reinvented? Heart 2002;88:1-3.
35. Solomon DH, Stone PH, Glynn RJ, et al. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol. 2001;38:969-76).
36. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
37. Parisi AF, Kuri S, Deupree RH, et al. Medical compared with surgical management of unstable angina pectoris: five year mortality and morbidity in the Veterans Administration study. Circulation 1989;80:1176-89.
38. Jafary F, Udelson JE. Assessment of myocardial perfusion and left ventricular function in acute coronary syndromes: implications for gated SPECT imaging. In:Germano and Berman. Cardiac gated SPECT imaging 1999.
39. Kawai Y, Tsukamoto E, Nozaki Y, et al. Significance of reduced uptake of iodinated fatty acid analogues for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001;38:1888-94.
40. Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: prospective study comparing pre discharge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321-6.
41. Volpi A, deVita C, Franzosi MG, et al. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppa Italiano per lo Studio della Sparavvivenza nell 'Infarto Moocardico (GISSI-2). J Am Coll Cardiol 1994;24(3):608-15.
42. Leppo JA, O'Brien J, Rothendler JA, et al. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-8.
43. Gimple LW, Hutter AM Jr, Guiney TE, et al. Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiograpny and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. Am J Cardiol 1989;64:1243-8.
44. Younis LT, Byers S, Shaw L, et al. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event. Am J Cardiol 1989;64:161-6.
45. Travin MI, Dessovki A, Cameron T, et al. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischaemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995;75:665-9.
46. Mahmarian JJ, Mahmarian AC, Marks GF, et al. Role of adenosine thallium-201 tomography for defining long term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995;25:1333-40.
47. 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 1997;96:2932-7.
48. TIMI Study Group. Comparison of invasive and conservative stategies after treatment with intravenous tPA in acute myocardial infarction: results of the thrombolysis in MI (TIMI) phase II trial. N Eng J Med 1989;320:618-27.
49. Ellis SG, Mooney MR, George BS, et al. Randomised trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment for myocardial infarction (TOPS Trial). Circulation 1992;86:1400-6.
50. 99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060-6.
51. Heller GV, Brown KA, Landin RJ, et al. Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Am Heart J 1997;134:105-11.
52. Takeishi Y, Sukekawa H, Fugiwira S, et al. Reverse redistribution of Tc-99m sestamibi following PTCA in acute myocardial infarction. J Nucl Med 1996;37(8):1289-94.
53. Leoncini M, Sciagra R, Bellandi F, et al. Low-dose dobutamine in late enhanced Tc-99m Sestamibi gated SPECT versus low-dose dobutamine echocardiography in detecting reversible dysfunction in ischaemic cardiomyopathy. J Nucl Cardiol 2002;9, 4:402-6.
54. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
55. Zaret BL, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of thrombolysis in myocardial infarction (TIMI) phase II study. J Am Coll Cardiol 1995;26:73-9.
56. Volpi A, deVita C, Franzosi MG, et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the Gruppa Italiano per lo Studio della Sporavvivenza nell 'Infarto Moocardico (GISSI-2) database. Circulation 1993;88:416-29.
57. Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischaemia in survivors of acute myocardial infarction: A prospective randomized pilot study. Circulation 1998;98:2017-23.
58. Sridhara BS, Dudzic E, Basu S, et al. Reverse redistribution of thallium-201 represents a low risk thrombolysed patient following myocardial infarction. Eur J Nucl Med 1994;21:1094-7.
59. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
60. Matsunari I, Schricke U, Bengel FM, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischaemia in patients with acute coronary syndromes. Circulation 2000;101:2579-85.
61. Hofstra L, Liem IH, Dumont EA, et al. Visualization of cell death in vivo in patients with acute myocardial infarction. Lancet 2000;356:209-12.